Inventor
Neil P. Desai
Inventor
Los Angeles, CA, US
Overview
Patents· 135 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes25%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations13%
B82YSpecific uses or applications of nanostructures10%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests5%
Y10TTechnical subjects covered by former us classification5%
C12NMicroorganisms or enzymes5%
A61LMethods or apparatus for sterilising materials or objects in general5%
C08FMacromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds5%
C09DCoating compositions, e.g. paints, varnishes or lacquers4%
A23LFoods, foodstuffs or non-alcoholic beverages, not otherwise provided for3%
PatentTitleYear
10,772,795Propofol formulations with non-reactive container closures202010,744,110Methods of treating lung cancer202010,745,440Peptides and nanoparticles for intracellular delivery of molecules202010,705,070Methods of assessing suitability of use of pharmaceutical compositions of albumin and poorly water soluble drug202010,682,420Breast cancer therapy based on hormone receptor status with nanoparticles comprising taxane202010,660,965Methods of enhancing drug delivery and effectiveness of therapeutic agents202010,592,305Application session and enhancement for a wearable electronic device202010,527,604Methods of assessing suitability of use of pharmaceutical compositions of albumin and paclitaxel202010,413,531Methods of treating bladder cancer201910,397,349Rule organization for efficient transaction pattern matching201910,328,031Methods of treating pancreatic cancer201910,258,565Intravascular delivery of nanoparticle compositions and uses thereof201910,206,887Prion free nanoparticle compositions and methods of making thereof20199,962,373Methods of treating bladder cancer20189,925,117'Propofol formulations with non-reactive container closures'20189,884,013'Intravascular delivery of nanoparticle compositions and uses thereof'20189,855,220'Methods of treating pancreatic cancer'20189,820,949'Methods of treatment of pancreatic cancer'20179,724,323'Breast cancer therapy based on hormone receptor status with nanoparticles comprising taxane'20179,675,578'Breast cancer therapy based on hormone receptor status with nanoparticles comprising taxane'20179,671,406'SPARC and methods of use thereof'20179,597,409'Methods of treating cancer'20179,569,326'Rule organization for efficient transaction pattern matching'20179,561,288'Combinations and modes of administration of therapeutic agents and combination therapy'20179,511,046'Methods of treating pancreatic cancer'20169,446,003'Prion free nanoparticle compositions and methods of making thereof'20169,409,903'Benzyl substituted triazine derivatives and their therapeutical applications'20169,399,071'Methods of treatment of pancreatic cancer'20169,399,072'Methods of treatment of pancreatic cancer'20169,393,318'Methods of treating cancer'20169,345,699'Isoquinoline, quinoline, and quinazoline derivatives as inhibitors of hedgehog signaling'20169,308,180'Compositions and methods for preparation of poorly water soluble drugs with increased stability'20169,193,782'Use of the SPARC microenvironment signature in the treatment of cancer'20159,149,455'Methods of treating melanoma'20159,101,543'Combinations and modes of administration of therapeutic agents and combination therapy'20159,096,660'SPARC binding antibodies and uses thereof'20159,091,697'Use of 2 anti-SPARC antibodies to predict response to chemotherapy for pancreatic adenocarcinoma'20159,078,902'Triazine derivatives and their therapeutical applications'20159,072,656'Propofol formulations with non-reactive container closures'20159,072,655'Propofol formulations with non-reactive container closures'20159,061,014'Intravascular delivery of nanoparticle compositions and uses thereof'20159,012,518'Compositions and methods of delivery of pharmacological agents'20159,012,519'Compositions and methods of delivery of pharmacological agents'20158,999,396'Breast cancer therapy based on hormone receptor status with nanoparticles comprising taxane'20158,946,169'SPARC and methods of use thereof'20158,927,019'Methods and compositions for treating recurrent cancer'20158,916,204'SPARC and methods of use thereof'20148,911,786'Nanoparticle comprising rapamycin and albumin as anticancer agent'20148,889,346'Propofol formulations with non-reactive container closures'20148,877,924'Benzyl substituted triazine derivatives and their therapeutical applications'20148,853,260'Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof'20148,846,771'Compositions and methods of delivery of pharmacological agents'20148,735,394'Combinations and modes of administration of therapeutic agents and combination therapy'20148,580,786'Triazine derivatives and their therapeutical applications'20138,476,010'Propofol formulations with non-reactive container closures'20138,420,603'SPARC and methods of use thereof'20138,415,304'Sparc and methods of use thereof'20138,383,358'Use of 2 anti-SPARC antibodies to predict response to melanoma chemotherapy'20138,314,156'Compositions and methods of delivery of pharmacological agents'20128,268,348'Combinations and modes of administration of therapeutic agents and combination therapy'20128,257,733'Methods and compositions for treating proliferative diseases'20128,137,684'Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof'20128,138,229'Compositions and methods of delivery of pharmacological agents'20128,034,765'Compositions and methods for preparation of poorly water soluble drugs with increased stability'20118,034,375'Combinations and modes of administration of therapeutic agents and combination therapy'20118,026,275'Compositions, methods of use and preparation of 2,6-diisopropyl phenol and analogs for ischemic injury'20117,981,445'Compositions and methods for preparation of poorly water soluble drugs with increased stability'20117,923,536'Compositions and methods of delivery of pharmacological agents'20117,858,782'Triazine derivatives and their therapeutical applications'20107,820,788'Compositions and methods of delivery of pharmacological agents'20107,816,346'Analogs of ansamycin and pharmaceutical compositions thereof'20107,799,954'Dicarbonyl derivatives and methods of use'20107,780,984'Methods and compositions for treating proliferative diseases'20107,771,751'Compositions comprising poorly water soluble pharmaceutical agents and antimicrobial agents'20107,758,891'Combinations and modes of administration of therapeutic agents and combination therapy'20107,700,612'Di-ester prodrugs of camptothecin, process for their preparation and their therapeutical applications'20107,674,816'Substituted melatonin derivatives, process for their preparation, and methods of use'20107,586,008'Propofol analogs, process for their preparation, and methods of use'20097,413,781'Gels for encapsulation of biological materials'20087,332,568'Q3 SPARC deletion mutant and uses thereof'20087,153,519'Implantable substrate coated with a macromer having free radical polymerizable substituents'20066,911,227'Gels for encapsulation of biological materials'20056,753,006'Paclitaxel-containing formulations'20046,749,868'Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof'20046,632,446'Coating substrates by polymerizing macromers having free radical-polymerizable substituents'20036,602,975'Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers'20036,565,842'Crosslinkable polypeptide compositions'20036,537,579'Compositions and methods for administration of pharmacologically active compounds'20036,528,067'Total nutrient admixtures as stable multicomponent liquids or dry powders and methods for the preparation thereof'20036,506,405'Methods and formulations of cremophor-free taxanes'20036,495,161'Cytoprotective biocompatible containment systems for biologically active materials and methods of making same'20026,465,001'Treating medical conditions by polymerizing macromers to form polymeric materials'20026,306,922'Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers'20016,258,870'Gels for encapsulation of biological materials'20016,096,331'Methods and compositions useful for administration of chemotherapeutic agents'20006,060,582'Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers'20005,997,904'Total nutrient admixtures as stable multicomponent liquids or dry powders and methods for the preparation thereof'19995,986,043'Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers'19995,916,596'Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof'19995,879,709'Method of treating patients with diabetes'19995,858,746'Gels for encapsulation of biological materials'19995,846,530'Macrocapsules prepared from crosslinkable polysaccharides, polycations and/or lipids and uses therefor'19985,843,743'Gels for encapsulation of biological materials'19985,837,747'Crosslinkable polysaccharides, polycations and lipids useful for encapsulation and drug release'19985,834,556'Graft copolymer of polycationic species and water-soluble polymers, and uses therefor'19985,834,274'Gels for encapsulation of biological materials'19985,801,033'Gels for encapsulation of biological materials'19985,788,988'Method for making cytoprotective, biocompatible, retrievable microcapsule containment systems'19985,780,653'Nitrophenyl, 10-deacetylated substituted taxol derivatives as dual functional cytotoxic/radiosensitizers'19985,759,578'Cytoprotective, biocompatible, retrievable macrocapsule containment systems for biologically active materials'19985,705,270'Microcapsules prepared from crosslinkable polysaccharides, polycations and/or lipids and use therefor'19985,700,848'Gel compositions prepared from crosslinkable polysaccharides, polycations and/or lipids and uses therefor'19975,665,383'Methods for the preparation of immunostimulating agents for in vivo delivery'19975,665,382'Methods for the preparation of pharmaceutically active agents for in vivo delivery'19975,650,156'Methods for in vivo delivery of nutriceuticals and compositions useful therefor'19975,648,506'Water-soluble polymeric carriers for drug delivery'19975,639,473'Methods for the preparation of nucleic acids for in vivo delivery'19975,635,207'Methods for the preparation of blood substitutes for in vivo delivery'19975,626,863'Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers'19975,578,442'Graft copolymers of polycationic species and water-soluble polymers, and use therefor'19965,573,934'Gels for encapsulation of biological materials'19965,567,435'Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers'19965,560,933'Methods for in vivo delivery of substantially water insoluble pharmacologically active agents and compositions useful therefor'19965,550,178'Process for encapsulating biologics using crosslinkable biocompatible encapsulation system'19965,545,423'Cytoprotective, biocompatible, retrievable macrocapsule containment systems for biologically active materials'19965,529,914'Gels for encapsulation of biological materials'19965,512,268'Polymeric shells for medical imaging prepared from synthetic polymers, and methods for the use thereof'19965,508,021'Non-fluorinated polymeric shells for medical imaging'19965,505,932'Method for the preparation of fluorocarbon-containing polymeric shells for medical imaging'19965,498,421'Composition useful for in vivo delivery of biologics and methods employing same'19965,439,686'Methods for in vivo delivery of substantially water insoluble pharmacologically active agents and compositions useful therefor'19955,410,016'Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers'19955,362,478'Magnetic resonance imaging with fluorocarbons encapsulated in a cross-linked polymeric shell'19945,334,640'Ionically covalently crosslinked and crosslinkable biocompatible encapsulation compositions and methods'19945,330,911'Surfaces having desirable cell adhesive effects'1994Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1994–2008Patents assigned to UNIV TEXAS (17)· patent assignee history
1994–2000Patents assigned to VIVORX PHARMACEUTICALS INC (15)· patent assignee history
1994–2019Based in Los Angeles, CA, US· patent location history
2008–2014Based in Santa Monica, CA, US· patent location history
2010–2020Patents assigned to ABRAXIS BIOSCIENCE LLC (62)· patent assignee history
2012–2020Patents assigned to DESAI NEIL P (20)· patent assignee history
2012–2017Patents assigned to SOON-SHIONG PATRICK (17)· patent assignee history
2013–2020Based in Pacific Palisades, CA, US· patent location history
2017–2019Based in Saratoga, CA, US· patent location history
2020Based in San Francisco, CA, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ABRAXIS BIOSCIENCE LLC | 62 | 2010–2020 |
| DESAI NEIL Pself | 20 | 2012–2020 |
| SOON-SHIONG PATRICK | 17 | 2012–2017 |
| UNIV TEXAS | 17 | 1994–2008 |
| VIVORX PHARMACEUTICALS INC | 15 | 1994–2000 |
Locations
| Location | Patents | Span |
|---|---|---|
| Los Angeles, California, US | 111 | 1994–2019 |
| Pacific Palisades, California, US | 15 | 2013–2020 |
| Santa Monica, California, US | 5 | 2008–2014 |
| Saratoga, California, US | 2 | 2017–2019 |
| San Francisco, California, US | 1 | 2020 |